State of the clinical research For both compounds, the published clinical research in humans is limited: BPC-157 has not received approval as a medicine in any major regulatory jurisdiction (UK MHRA, EU EMA, US FDA)
Some of the peptides reviewed here are banned in Olympic sport but not yet in professional sport, or only in one league but not another showing the challenges these peptides present to anti-doping administrators and sports leagues
Management of ACL requires a multimodal approach that may include: Drugs : NSAIDs (non-steroidal anti-inflammatories) Analgesics: for pain Physiotherapy Regenerative Therapy: stem cell therapy, PRP, Laser, Peptides Therapeutic Supplements: Joint support, comfort, anti inflammatory Surgery: TPLO ACL Tear in Bulldogs and French Bulldogs SURGERY REPAIR: Bulldog and French Bulldog ACL tear surgery goals are to stabilize the knee joint and do so early to minimize DJD (Degenerative Joint Disease, Bulldog Arthritis, )
People Looking to Improve Skin Health Patients recovering from cosmetic procedures or those looking to improve skin texture, firmness, and overall appearance may benefit from the regenerative properties of GHK-Cu
Similarly, MOTS-c is banned in sport because it is not an approved therapeutic drug
The risks of BPC-157 are listed below